Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population
- 7 November 2002
- Vol. 21 (15) , 1687-1693
- https://doi.org/10.1016/s0264-410x(02)00632-1
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenzaThe Lancet, 2001
- Antibody Response in Individuals Infected with Avian Influenza A (H5N1) Viruses and Detection of Anti‐H5 Antibody among Household and Social ContactsThe Journal of Infectious Diseases, 1999
- ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virusVaccine, 1999
- Human influenza A H5N1 virus related to a highly pathogenic avian influenza virusThe Lancet, 1998
- Molecular analysis of an outbreak of influenza in the United KingdomEuropean Journal of Epidemiology, 1997
- Receptor Specificity in Human, Avian, and Equine H2 and H3 Influenza Virus IsolatesVirology, 1994
- Summary of Clinical Trials of Influenza Virus Vaccines in AdultsThe Journal of Infectious Diseases, 1977